Keywords: promising, data, maxim, maxamine, biopharmaceutical, company, pharmaceuticals

Promising Data With Maxim's Maxamine

Article | 04 November 1996

Print This

US biopharmaceutical company Maxim Pharmaceuticals has released positive data from its ongoing Phase II trial with Maxamine (an H2 agonist) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in